About HDFC Debt Fund for Cancer Cure
For the first time in India, a mutual fund investment allows you to contribute for a noble cause. The scheme offers 50% and 100% dividend payout option whereby investors can donate the respective percentage of dividend income earned from the fund, i.e., 50% and 100% to the Indian Cancer Society* as a financial assistance to the ill and needy patients (with annual household income less than 1.5 lakhs). The HDFC Debt Fund for Cancer Cure would invest mainly in fixed income and money market instruments having a tenure that is in line with the period of the fund. Being a social initiative, HDFC shall not charge any investment management and advisory fees to this fund.
Benefit under the Income Tax Act, 1961: The investor of HDFC Debt Fund for Cancer Cure would be eligible to receive tax deduction under Section 80G of the Income- tax Act, 1961 on the amount of donation made to Indian Cancer Society.
- Fund Manager: Anil Bamboli
- Investment Strategy: The net assets of the Scheme will be predominantly invested in highly rated fixed income securities like Debt, Money market instruments and Government Securities maturing on or before the maturity date of the Scheme. The primary objective of the Scheme is to endeavor to protect the capital and generate income through investments in high quality fixed income securities like Debt / Money Market Instruments and Government Securities maturing on or before the maturity date of the Scheme
- Minimum application amount: 1 Lakh
- Scheme Rating: AAA (sovereign) by CRISIL
- NFO period: February 18 – March 4, 2011
- Redemption: 3 years after date of allotment
To Buy, Click here
*The Indian Cancer Society (ICS), a Public Charitable Trust is India’s oldest anti cancer NGO established in 1951. It provides affordable and innovative solutions for the detection and treatment of Cancer, and for the post rehabilitation of survivors and is dedicated to the fight against cancer through its numerous countrywide activities. (To know more about ICS, visit website- www.indiancancersociety.org)
Disclaimer: iFAST and/or its content and research team’s licensed representatives may own or have positions in the mutual funds of any of the Asset Management Company mentioned or referred to in the article, and may from time to time add or dispose of, or be materially interested in any such. This article is not to be construed as an offer or solicitation for the subscription, purchase or sale of any mutual fund. No investment decision should be taken without first viewing a mutual fund's scheme information document including statement of additional information. Any advice herein is made on a general basis and does not take into account the specific investment objectives of the specific person or group of persons. Investors should seek for professional investment, tax, and legal advice before making an investment or any other decision. Past performance and any forecast is not necessarily indicative of the future or likely performance of the mutual fund. The value of mutual funds and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. Please read our disclaimer on the website.Please read our disclaimer in the website. Risk Factors: Mutual funds, like securities investments, are subject to market risks and there is no guarantee against loss in the Scheme or that the Scheme’s objectives will be achieved. As with any investment in securities, the NAV of the Units issued under the Scheme can go up or down depending on various factors and forces affecting capital markets. Past performance of the Sponsor/the AMC/the Mutual Fund does not indicate the future performance of the Scheme. The name of the Scheme does not in any manner indicate the quality of the Scheme, its future prospects or returns. Please read the Statement of Additional Information and Scheme Information Document carefully before investing.